Demonstrating Quality Under a Value-Based Insurance Design

Marc O'Connor, COO and chief strategy officer for Curant Health, discusses how specialty pharmacies can demonstrate value as the use of value-based care designs increase.

Related Content:

InterviewsReimbursementSpecialty Pharmacy

Treatment with Ofatumumab Increases Number of Patients Who Achieve No Evidence of Disease Activity for MS

Bringing Oncology Pharmacy Leaders, Payers Together to Address Unmet Educational Needs in the Field

Oncology Overview: Sonidegib (Odomzo) for Locally Advanced Basal Cell Carcinoma